Illumina shells out $100M for Edico Genome acquisition

Illumina Inc. (NASDAQ:ILMN) will acquire genome analytics company Edico Genome Inc. (La Jolla, Calif.) for $100 million.

SVP of

Read the full 181 word article

User Sign In